樂歌股份(300729.SZ):擬約5.5億元投資建造美國佐治亞州Ellabell海外倉項目
格隆匯6月17日丨樂歌股份(300729.SZ)公佈,為進一步提升公司競爭力,加速公司公共海外倉業務發展,公司下屬全資孫公司Ellabell Bryan Lecangs LLC擬與Clayco,Inc.簽訂“美國佐治亞州Ellabell海外倉項目”建造合同,建造總價預計7,800萬美元(摺合人民幣約5.5億元)。
“美國佐治亞州Ellabell海外倉項目”為公司向特定對象發行股票的募投項目,本次建造所需資金由公司先行投入,待公司向特定對象發行股票募集資金到位後予以置換。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.